Digital Support Intervention for Pregnant People with Opioid Use Disorders
PARENTSS
Exploring the Preliminary Effects of a Digital Parenting and Recovery Support Intervention for Pregnant People Seeking Recovery from Opioid Use Disorders: a Pilot Randomized Control Trial
1 other identifier
interventional
32
1 country
1
Brief Summary
The goal of this pilot randomized feasibility study is to explore the benefits of providing parenting and recovery support for pregnant people with Opioid Use Disorders through digital technology (e.g. smartphones). The main question it aims to answer is:
- What is the feasibility of providing customized digital parenting and recovery supports to pregnant people with Opioid Use Disorders residing in natural communities? o Feasibility data includes data on study interest, eligibility, time to enroll, participant training on digital app usage, attrition; Secondary outcome exploratory data will include MOUD treatment retention, missed follow up prenatal and early postpartum appointments, drug usage, and parenting outcomes (i.e., scores on the Parental sense of competency scale, Self-rated abilities for health practices scale, and Self-efficacy in infant care scale) through self-report; The intervention group only will also be observed regarding app usage, frequency of use, resources accessed, thoughts about the app, and what was found to be helpful. Researchers will compare the bibliotherapy control group to determine clinical differences in secondary outcomes. Participants will complete the following tasks:
- Schedule an online meeting with the research team to receive more information about the study. Once consented to participate, the participant will be randomly assigned to one of the groups.
- Complete survey questions within one week after agreeing to participate in the study, after 6 weeks, and 12 weeks. The surveys include questions about drug usage, missed follow-up medical appointments, and parenting outcomes. The total time to complete the survey after consenting to be in the study will take approximately 40 minutes. The total time to complete the surveys after the six week and 12-week study period should take no more than 30 minutes.
- Complete a one-hour virtual interview at three months post-delivery (by phone or computer) about the study experience.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for early_phase_1
Started Jun 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 4, 2024
CompletedFirst Submitted
Initial submission to the registry
September 16, 2024
CompletedFirst Posted
Study publicly available on registry
October 22, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 28, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedFebruary 17, 2025
September 1, 2024
1.2 years
September 16, 2024
February 13, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Recruitment and Retention: Number of communications regarding study interest, number of interested persons eligible/ineligible, No. of study refusals; study attrition rates
Recruitment - recruitment measures (e.g., total time, direct calls regarding interest, number eligible/ineligible, refusals) (Qualitative) Qualitative data via interviews at the end of the study period with each participant in the Intervention group regarding type of smart phone used/model; overall experience using the app, times and situations when participants were more likely to use app as a resource, app features most helpful in supporting recovery from OUD, app features most helpful in supporting parenting, and preferences regarding initiation of intervention. Attrition data --duration of time that individuals engaged with the app; participated in the study
12 week study period; final data collection (qualitative interview) at 3 months post-delivery
Secondary Outcomes (5)
Treatment retention: Qualitative interview 3 months post delivery: responses to questions regarding status in treatment for Opioid Use Disorder, attendance to postpartum appointments, scheduled baby visits.
Qualitative interview at 3 months post-delivery
Recovery Capital: Quantitative measure: Total scores on the Brief Assessment of Recovery Capital scale.
12 week study period; final data collection (qualitative interview) at 3 months post-delivery
Parenting outcomes: Quantitative measures: Total scores on the self-rated abilities for health practices scale (SRAHP)
12 week study period
Parenting outcomes: Quantitative measures: Total scores on the parental sense of competence scale (PSOC)
12 week study period
Parenting outcomes: Quantitative measures: Total scores on the self-efficacy in infant care scale (SICS)
12 week study period
Study Arms (2)
Customized Digital Application group (Intervention)
EXPERIMENTALParticipants are assigned to one of two groups where they will receive one type of parenting support. The intervention group will receive a smartphone app which provides access to comprehensive resources related to parenting and recovery. The intervention group will be observed to determine how frequently they use the digital app, thoughts about it, and what was found to be helpful. This will occur over a 12-week period. The intervention group will complete surveys over the study period through the digital app. The times for survey completion are within one week after agreeing to participate in the study, after 6 weeks, and 12 weeks. The surveys include questions about personal history, drug usage and cravings, missed follow-up medical appointments, and parenting outcomes. An interview with the PI at 12 weeks post-delivery.
Parenting book as support for control group
ACTIVE COMPARATORThe bibliotherapy control group will receive a book on what to expect as a parent the first year after delivery. The control group will complete surveys over the study period and are given the option to complete surveys by phone or videoconference with a Team member. The times for survey completion are within one week after agreeing to participate in the study, after 6 weeks, and 12 weeks. The surveys include questions about personal history, drug usage and cravings, missed follow-up medical appointments, and parenting outcomes. An interview with the PI at 12 weeks post-delivery.
Interventions
The digital app is a customized comprehensive self-management platform designed to provide recovery and parenting support for individuals with substance use disorders.
Bibliotherapy control group will receive parenting book what to expect the first year.
Eligibility Criteria
You may qualify if:
- Female, pregnant, greater 13 weeks gestational age
- Opioid Dominant Use Disorder and Primary Phenotype
- Residing in natural home environment
- minimum of 18 years of age
- Able to speak and understand English
- Able to understand and provide informed consent
You may not qualify if:
- Not pregnant, has active illicit opioid use and not currently in treatment
- a violent criminal history
- cannot read and communicate in English
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
MUSC Health Institute of Psychiatry
Charleston, South Carolina, 29425, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Phyllis A Raynor, PHD
University of South Carolina
Study Design
- Study Type
- interventional
- Phase
- early phase 1
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Assistant Professor
Study Record Dates
First Submitted
September 16, 2024
First Posted
October 22, 2024
Study Start
June 4, 2024
Primary Completion
August 28, 2025
Study Completion
December 31, 2025
Last Updated
February 17, 2025
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will not share
primary feasibility outcome data and secondary treatment retention data will be shared in aggregate to protect participant confidentiality.